Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV

AIDS

Volumn 14, Issue 2, 2000, Pages 117-121

  Vernazza, Pietro L ^c   Troiani, Luigi ^b   Flepp, Markus J ^a   Cone, Richard W ^a   Schock, Jody ^a   Roth, Felix ^a   Boggian, Katia ^a   Cohen, Myron S ^b   Fiscus, Susan A ^a   Eron, Joseph J ^b  

^a Department of Microbiology ^*

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c KSSG   (Switzerland)

Author keywords

Antiretroviral therapy; Heterosexual transmission; Semen; Viral load

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEMEN ANALYSIS; SEXUAL TRANSMISSION; VIRUS LOAD; VIRUS SHEDDING;

ANTI-HIV AGENTS; COHORT STUDIES; DNA, VIRAL; HIV; HIV INFECTIONS; HUMANS; MALE; POLYMERASE CHAIN REACTION; PROVIRUSES; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SEMEN; VIRAL LOAD;

EID: 0005433724     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200001280-00006     Document Type: Article

References (25)

1. 1. Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ 1997, 315:1194-1199.
2. 2. Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997, 276:960-964.
3. 3. Mayers D, Bethel J, Wainberg MA, Weislow O, Schnittman S, Div AIDS Treat Res Init. Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74). J Infect Dis 1998, 177:1730-1733.
4. 4. Perrin L, Yerly S, Marchal F, Schockmel GA, Hirschel B, Fox CH, et al. Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy. J Infect Dis 1998, 177:1497-1501.
5. 5. Vernazza PL, Eron JJ, Fiscus SA, Cohen MS. Sexual transmission of HIV: Infectiousness and prevention. AIDS 1999, 13: 155-166.
6. 6. Gilliam BL, Dyer JR, Fiscus SA, Marcus C, Zhou S, Wathen L, et al. Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 15:54-60.
7. 7. Vernazza PL, Gilliam BL, Flepp M, Dyer JR, Frank AC, Fiscus SA, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 1997, 11:1249-1254.
8. 8. Gupta P, Mellors J, Kingsley L, Riddler S, Singh MK, Schreiber S, et al. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 1997, 71:6271-6275.
9. 9. Zhang H, Dornadula G, Beumont M, Livornese L, Van Uitert B, Henning K, et al. Human Immunodeficiency virus type-1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998, 339:1803-1809.
10. 10. Byrn RA, Zhang DZ, Eyre R, McGowan K, Kiessling AA. HIV-1 in semen: an isolated virus reservoir. Lancet 1997, 350: (9085):1141-1141.
11. 11. Delwart EL, Mullins JI, Gupta P, Learn GH, Holodniy M, Katzenstein D, et al. Human immunodeficiency virus type 1 populations in blood and semen. J Virol 1998, 72:617-623.
12. 12. Eron JJ, Vernazza PL, Johnston DM, Seillier-Moiseiwitsch F, Alcorn TM, Fiscus SA, et al. Resistance to HIV-1 to antiretroviral agents in blood and seminal plasma: Implications for transmission. AIDS 1998, 12:F181-F189.
13. 13. Kiessling AA, Fitzgerald LM, Zhang DZ, Chay H, Brettier D, Eyre RC, et al. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res Hum Retro 1998, 14:S33-S41.
14. 14. Schockmel GA, Yerly S, Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:179-183.
15. 15. Dyer JR, Gilliam BL, Eron JJ, Grosso L, Cohen MS, Fiscus SA. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods 1996, 60:161-170.
16. 16. Vernazza PL, Gilliam BL, Dyer JR, Fiscus SA, Eron JJ, Frank AC, et al. Quantitation of HIV in semen: Correlation with antiviral treatment and immune status. AIDS 1997, 11:987-993.
17. 17. Coombs RW, Speck CE, Hughes JP, Lee W, Sampoleo R, Ross SO, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998, 177:320-330.
18. 18. Anderson J, Armstead R, Baker AC, Barr D, Bozzette S, Cox S, et al. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Ann Intern Med 1998, 128:1079-1100.
19. 19. Eron JJ, Smeaton L, DeGruttola V, Schock J, Fiscus S, Tung R, et al. The effects of Amprenavir (APV) alone or in combination with ZDV/3TC, on HIV-1 levels in Semen: a substudy of ACTG 347. 6th Retrovirus Conference, Chicago, Feb. 1-4, 1999 [Abstract 222].
20. 20. Vernazza PL, Eron JJ, Fiscus SA. Sensitive method for the detection of infectious HIV in semen of seropositive individuals. J Virol Methods 1996, 56:33-40.
21. 21. Sodora DL, Gettie A, Miller CJ, Marx PA. Vaginal transmission of SIV: Assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retro 1998, 14:S119-S123.
22. 22. Krieger JN, Coombs RW, Collier AC, Ross SO, Chaloupka K, Cummings DK, et al. Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J Infect Dis 1991, 163: 386-388.
23. 23. Anderson DJ, Obrien TR, Politch JA, Martinez A, Seage GR, Padian N, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type-1 in semen. JAMA 1992, 267:2769-2774.
24. 24. Vernazza PL, Eron JJ, Cohen MS, van der Horst CM, Troiani L, Fiscus SA. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 1994, 8:1325-1329.
25. 25. Vernazza PL, Dollenmaier G, Gowland PL, Roth F, Eron, JJ, Fiscus SA. Quantitative HIV-DNA detection in semen of HIV infected individuals: Correlation with HIV-RNA and culture. 5th Conf Retro and Opportunistic Infect, Chicago, February 1-5 1998 [Poster 190].